PATENT CLAIM ANALYSIS

Application Number: 15920361
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "007600"]

Abstract:
The invention relates to the use of a Mechano Growth Factor (MGF) polypeptide or a polynucleotide encoding an MGF polypeptide in the manufacture of a medicament for the prevention or limitation of myocardial damage in response to ischemia or mechanical overload of the heart by preventing or limiting apoptosis in the myocardium.

Claim (Index 2):
The method of  claim 1 , wherein the MGF polypeptide is unglycosylated.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09408905', '12689906', '11429203', '11429027', '13369837']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7413472374572821
- 35 USC 102 Novelty (BERT): 0.5313286487101364
- Combined Prediction Score: 0.7203453785825676
- Mean Citation Score: 280.90277000000003
- Max Citation Score: 311.03372
- Similarity Product: 192.129490209818

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test